SCHEMBL6920087

SCHEMBL6920087

Cn1nc(Cc2ccccc2)c(C(=O)c2cccnc2)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
KMT2A Q03164 3/20 0.47
TDP1 Q9NUW8 1/20 0.47
PLOD2 O00469 1/20 0.43
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GAA P10253 3/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 3/20 0.41
APP P05067 1/20 0.41
HCAR3 P49019 1/20 0.41
HCAR2 Q8TDS4 1/20 0.41
GPR52 Q9Y2T5 1/20 0.41
EPHX2 P34913 1/20 0.41
TBXAS1 P24557 3/20 0.40
VNN1 O95497 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6918790 0.86 LMNA (0.42) LMNAKMT2ATDP1PLOD2MEN1
SCHEMBL6918282 0.85 ALDH1A1 (0.42) LMNAKMT2APLOD2NPC1RAB9A
SCHEMBL2214214 0.82 ALDH1A1 (0.43) LMNATDP1PLOD2GAATSHR
SCHEMBL6921905 0.81 LMNA (0.41) LMNAKMT2ATDP1PLOD2RAB9A
SCHEMBL6820177 0.81 ALDH1A1 (0.42) LMNAKMT2APLOD2MEN1NPC1
SCHEMBL6919835 0.81 L3MBTL1 (0.47) LMNAKMT2AMEN1NPC1RAB9A
SCHEMBL6916106 0.79 LMNA (0.46) LMNAKMT2ATDP1PLOD2SMN1; SMN2
SCHEMBL6921251 0.78 TSHR (0.49) LMNAKMT2ATDP1PLOD2MEN1
SCHEMBL6919778 0.74 ALDH1A1 (0.41) LMNAGAATSHRALDH1A1APP
SCHEMBL6920743 0.74 NPC1 (0.42) NPC1RAB9ASMN1; SMN2GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004033431-A2 HYDROXYPYRAZOLES FOR USE AGAINST METABOLIC-RELATED DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2004-04-22 WO claimed
WO-2004033431-A2 HYDROXYPYRAZOLES FOR USE AGAINST METABOLIC-RELATED DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2004-04-22 WO disclosed